Market Tracker

11/21 6:05pm ET

Repligen Corp (NASDAQ:RGEN)

22.89
Data as of Nov 21
 +0.02 / +0.09%
Today’s Change
11.70
Today|||52-Week Range
26.75
+67.82%
Year-to-Date

Today’s Trading

Previous close22.87
Today’s open23.25
Day’s range22.77 - 23.57
Volume222,135
Average volume (3 months)378,287
Market cap$749.0M
Dividend yield--
Data as of 3:59pm ET, 11/21/2014

Growth & Valuation

Earnings growth (last year)+11.11%
Earnings growth (this year)-47.33%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+9.48%
P/E ratio63.6
Price/Sales6.34
Price/Book7.03

Competitors

 Today’s
change
Today’s
% change
MGNXMacroGenics Inc+1.11+4.25%
EPZMEpizyme Inc-1.07-4.54%
OREXOrexigen Therapeutic...+0.12+2.08%
RGLSRegulus Therapeutics...+0.54+3.44%
Data as of 3:59pm ET, 11/21/2014

Financials

Next reporting dateMarch 5, 2015
EPS forecast (this quarter)$0.03
Annual revenue (last year)$68.2M
Annual profit (last year)$16.1M
Net profit margin23.61%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Treasurer, Director &
CAO
Walter C. Herlihy
Chief Operating Officer
Tony J. Hunt
Corporate headquarters
Waltham, Massachusetts

Forecasts